Dietary Supplement
Snack
Snack is a dietary supplement with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
75%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (25.0%)
N/A3 (75.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_2
Evaluation of Common Bean Baked Snack Consumption on Blood Lipids in Overweight People With Altered Blood Lipid Levels
NCT05028699
completednot_applicable
Carbohydrate-based Strategies to Prevent Exercise-induced Hypoglycemia
NCT03214107
completednot_applicable
The Benefits of Consuming Hummus as an Afternoon Snack
NCT03595462
completednot_applicable
Effects of Hazelnuts and Cocoa on Metabolic Parameters and Vascular Reactivity
NCT02845622
Clinical Trials (4)
Showing 4 of 4 trials
NCT05028699Phase 2
Evaluation of Common Bean Baked Snack Consumption on Blood Lipids in Overweight People With Altered Blood Lipid Levels
NCT03214107Not Applicable
Carbohydrate-based Strategies to Prevent Exercise-induced Hypoglycemia
NCT03595462Not Applicable
The Benefits of Consuming Hummus as an Afternoon Snack
NCT02845622Not Applicable
Effects of Hazelnuts and Cocoa on Metabolic Parameters and Vascular Reactivity
All 4 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 4